Case Summary
No summary as outwith the scope of the Code
AUTH/3482/3/21 - Complainant v GlaxoSmithKline
Alleged promotion of Nucala (mepolizumab) on LinkedIn
-
Case numberAUTH/3482/3/21
-
Complaint received04 March 2021
-
Completed01 December 2021
-
Appeal hearingNo appeal
-
Applicable Code year2019
-
Additional sanctions